ArticleFrontiers in oncology2026

CKAP2L promotes endometrial cancer progression by suppressing AKT ubiquitination and activating the PI3K/AKT signaling pathway.

Min Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.